Rates of other complications, including TLS, AKI, RBS, and platelet transfusion, were also higher in the CMV group compared to the non-CMV group; however, these differences did not reach statistical significance (Table 4 ).
← all excerpts
Cytomegalovirus Infection and Clinical Outcomes in Hospitalized Chimeric Antigen Receptor T-Cell Therapy Recipients.
1
—
—